Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DDI Study of Telmisartan/Amlodipine and Atorvastatin
NCT03461081Phase 1Completed
- Sponsor
- Jeil Pharmaceutical Co., Ltd.
- Start
- May 2017
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of telmisartan and amlodipine in hypertension (HTN) and hyperlipidemia (2 arms), sponsored by Jeil Pharmaceutical Co., Ltd. Primary endpoints: Area under the concentration-time curve over the dosing interval and Maximum steady-state plasma concentration. Started May 2017; status: completed.
02
Drugs
telmisartanamlodipine
03
Conditions
hypertension (HTN)hyperlipidemia
Beyond the preview
Go deeper on NCT03461081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03461081.